Source Documents and Regulatory Binders October 6, 2016

Similar documents
Regulatory Binder Guidance

Regulatory Binder: Set-up and Maintenance

Standard Operating Procedures Guidelines for Good Clinical Practice

Human Research Protection Program Good Clinical Practice Guidance for Investigators Regulatory File Essential Documents

Quality Assurance QA STANDARD OPERATING PROCEDURE FOR FDA or Pharmaceutical Sponsored Audits

ROLE OF THE RESEARCH COORDINATOR Investigational New Drug Application-Sponsor Responsibilities 21CFR Part , subpart D

Guidelines for Setting Up a Regulatory Binder

4.2. Investigator Regulatory Binder: Files, usually a binder, maintained by the investigator at the investigative site.

Investigator Site File Index (CTIMP)

SELF-ASSESSMENT CHECKLIST

Compliance and Quality Monitoring: What, Why, When, and How

ESSENTIAL DOCUMENTS FOR THE CONDUCT OF A CLINICAL TRIAL

Source And Regulatory Documentation for DMID Clinical Studies

FDA Sponsor and Investigator Responsibility Checklist

OFFICE FOR RESEACH PROCEDURE. Site Initiation and Close-out

POST-IRB APPROVAL FDA DRUG (IND) SPONSOR AND INVESTIGATOR RESPONSIBILITY (21 CFR312)

Regulatory Document Guidelines for DMID Clinical Studies. Version Oct-2005

Study Management SM STANDARD OPERATING PROCEDURE FOR Specimen Management

Presented by NC TraCS Institute UNC Office of Clinical Trials UNC Network for Research Professionals

Investigator Site File Index (Medical Devices)

ELEMENTS OF A DATA MONITORING PLAN

Details: Approval: Distribution & Storage:

Objectives. The Regulatory Binder = Investigator Site File= Trial Center File 8/16/2010. Essential Documents: Maintaining the Site's Regulatory Binder

Quality Assurance for the Research Team: Connecting Day-to-Day Operations to a Regulatory Framework

St. Luke s University Health Network

Study Files and Filing

Louise Brook Clinical Trials Quality Monitor. Date

ESSENTIAL DOCUMENTS DURING THE CLINICAL CONDUCT OF THE TRIAL

ROLE OF THE RESEARCH COORDINATOR Study Startup Best Practices May 2016

Implementing Good Clinical Practice at an Academic Research Institution

Objectives Discuss the importance of proper data collection. Identify the types of data collected for clinical trials. List potential source documents

Multi-Site Coordination Process. Drafted by: Ester Dimayuga Page 1 of 18

Investigator s Responsibility

Regulatory Documentation and Submissions for C2012 Clinical Trials DCP SOP #1

1.4 Applicable Regulatory Requirement(s) Any law(s) and regulation(s) addressing the conduct of clinical trials of investigational products.

Good Clinical Practice

STANDARD OPERATING PROCEDURE. STH Researcher. Investigator Site File

Standard Operating Procedures (SOPs)

GCP INSPECTION FINDINGS Singapore Research Ethics Conference 2018

Index of Standard Operating Procedures for all research Sponsored by the UHL

National Institute of Allergy and Infectious Diseases National Institutes of Health Department of Health and Human Services

Demystifying Audits. Audits and Audit Preparation 5/23/2016. What is an Audit?

1. POLICY STATEMENT: 2. BACKGROUND:

Show Me Your Docs! A REVIEW OF UNIVERSITY OF PITTSBURGH GUIDELINE: STUDY DOCUMENTATION FOR FDA REGULATED RESEARCH

Guidance for Industry - Computerized Systems Used in Clinical Trials

Sponsor-Investigator Responsibilities In Clinical Trials

and Study Initiation

and Study Initiation

1 The Clinical Research Coordinator (CRC)... 1

Clinical Research with Drugs/Biologics and Devices & Good Clinical Practices

Index of Standard Operating Procedures for all research Sponsored by the UHL

Investigator-Initiated INDs

Investigational New Drug Development Steps for CRCs

Annex IV to guidance for the conduct of good clinical practice inspections sponsor and CRO

Views of a Clinical Study Report

ORC Sponsor-Investigator IDE Checklist

Human Research Protection Program Policy

Conducting and reporting a GCP Inspection. Gunnar Danielsson Medical Products Agency

Clinical Trial Basics:

Implications for Investigator Initiated Trials (IITs)- Risk Based Approaches in Managing Clinical Trials

Audit and Regulatory Inspection Nopanan Yaibuathes Clinical Research and Compliance Manager Roche Thailand Ltd.

Research Study Close-down and Archiving Procedures

STANDARD OPERATING PROCEDURE FOR RESEARCH. 17. Study Close Down

RESEARCH AUDIT Standard Operating Procedure

Risk-Based Monitoring: How Can It Be Implemented For More Effective Study Oversight

IRB-GCP and Timelines. Andrew Majewski, MSc. 1 st DOLF Meeting Washington University School of Medicine St Louis, Missouri-USA October th, 2010

The European Medicines Agency Inspections ANNEX IV TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA:

EVENT TYPE TIMING REQUIRED FORM

11.0 FDA-Regulated Research

Preparing for Close-Out of Studies and Sites

Trial Master File. SOP No. SOP 7

Topics summarised in this presentation are: method for defining quality level you want meaning of external controls quality assurance activities

I. Purpose. II. Definitions. Last Approval Date

Sponsoring an IND? Ignorance is Not Always Blissful

Standard Operating Procedures (SOP) Research and Development Office

11.0 FDA-Regulated Research Research Involving Investigational Drugs and Biologics

\\NAS1\George\Docs\SoCRA\CCRP communications\study guide management

LOUGHBOROUGH UNIVERSITY RESEARCH OFFICE STANDARD OPERATING PROCEDURE. Loughborough University (LU) Research Office

11.0 FDA-Regulated Research Research Involving Investigational Drugs and Biologics

FDA Audit Preparation

Clinical Trials and the Code of Federal Regulations. Darlene Kitterman, MBA Director, Investigator Support & Integration Services September 24, 2014

3.1. Overall Principal Investigator (PI), who holds the IND and is the Sponsor.

Standard Operating Procedure

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

GCP Basics - refresher

Incorporating Risk- Based Monitoring Strategies: Challenges in Implementation Sherri Hubby, Director, U.S. Quality Assurance

3.1. Overall Principal Investigator (PI), who holds the IND and is the Sponsor.

Vanessa Laroche, CCRC, CCRA, CIP, CQA Quality Assurance Specialist Technical Resources International (TRI), Inc.

PHARMACY, MEDICINES & POISONS BOARD

CONTACT INFORMATION. PHRC Office. Josephine O Driscoll-Davis. Michael Ducey

UC Irvine s Clinical Research Coordinator Certification Preparation Series PI Roles and Responsibilities

TOP 10 INVESTIGATOR RESPONSIBILITIES WHEN CONDUCTING HUMAN SUBJECTS RESEARCH

Trial Master File / Investigator Site File Index Clinical Trials of Investigational Medicinal Products

Compliance Program Guidance Manuals (CPGMs) -1-

INVESTIGATIONAL DRUG MANAGEMENT OVERVIEW

It s All About The RISK

Clinical Trials Management for Molecular Diagnostics. April 2016

Data Management & Case Report Form Development in Clinical Trials. Introduction to the Principles and Practice of Clinical Research.

Introduction to Clinical Research

DATA INTEGRITY IN CLINICAL RESEARCH. Singapore Clinical Research Professional (CRP) Forum 25 August 2017

Transcription:

Source Documents and Regulatory Binders October 6, 2016 Lisa Wilson, Regulatory Lead, Clinical Trials Office and Mark Alger, CRC, Clinical Trials Office

Essential Documents AKA: the stuff in the Reg Binder

What are Essential Documents? Essential documents are those documents which individually and collectively permit evaluation of the conduct of the trial and the quality of the data produced. These documents serve to demonstrate the compliance of the investigator, sponsor and monitor with the standards of Good Clinical Practice and with all applicable regulatory requirements (ICH Guideline E6).

Clinical Trials Office webpage http://www.ucdmc.ucdavis.edu/clinica ltrials/forinvestigators/index.html - Clinical Study Management Helpful Templates

Essential Documents Signed Protocol and Amendments to document investigator and sponsor agreement to the protocol and any amendments Current protocol and all previously approved versions When applicable, a copy of the fully executed protocol signature page for original protocol and all approved versions

Protocol Signature Page

Essential Documents Investigator Brochure (if applicable) - To document that relevant and current scientific information about the investigational product has been provided to the investigator. Current IB and all previously approved versions When applicable, a copy of the IB signature page for original protocol and all approved versions

Essential Documents CVs and Licensure to document qualifications and eligibility to conduct trial and/or supervise medical supervision of subjects Signed and dated CVs for all study staff Valid medical licenses/professional certifications for all study staff

Medical License Make sure its not expired

Essential Documents FDA Form 1572 Statement of Investigator, documents the PI agreement to accept responsibility for the study, specifically to: 1) Follow the protocol, 2) Personally conduct or supervise the trial, 3) Obtain IRB approval and informed consent of subjects, 4) Report any adverse events, 5) Have read the IB and understand the risks and side effects, 6) To ensure that everyone working on the study is informed and trained on the above items, 7) To maintain accurate records and to make the records available for inspection, 8) To ensure that IRB approval is maintained, all unanticipated problems are reported to the IRB and that no changes will be made without IRB approval (except for immediate safety concerns). An FDA-1572 is required for drug or biologic studies conducted under an IND, whether in the U.S. or abroad.

Essential Documents IRB Approvals to document that the trial has been subject to IRB review and has been given approval. As well as to identify the version date of the documents. Approval letters and/or notification of IRB decisions. Investigator response(s) to IRB notification (if applicable). Approved recruitment materials. Approved educational materials/additional study information distributed to subjects (e.g., subject diary). Memo regarding FWA, IRB registration. Copy of IRB membership roster.

IRB Approval Letter

Essential Documents IRB Approved Consent Form to document that the Informed Consent Form has been subject to IRB review and has been given approval. As well as to identify the version date of the documents. Current IRB-approved consent and/or assent form version(s) with the IRB approval stamp.

Essential Documents Logs Staff Delegation of Authority/Delegation of Responsibility Log: documents the study-related procedures delegated to staff. The PI should initial, sign and date this list, and update it as new staff or study procedures are added to the protocol. Training Log: documents training of all study staff on protocol-related procedures.

Essential Documents Logs Subjects Pre-Screening Log: Captures subjects who have been pre-screened to determine initial eligibility for enrollment. Enrollment Log: Captures all subjects who sign a consent form. Adverse Event Tracking Log: Tracks and ensures timely reporting of all applicable adverse events to the IRB. This is often done electronically. Minor Deviation/Violation Tracking Log: Provides a record of all minor deviations from the approved protocol and facilitates reporting at continuing review. This is often done electronically. Tissues and/or Blood Sample Log: Tracks tissue and/or blood samples collected during research.

Essential Documents Lab Documents to document normal values and/or ranges of tests as well as to document qualifications of lab. Current Lab Certification (e.g., CLIA, CAP). Normal Lab/Reference Values. Available at: https://www.testmenu.com/ucdavis

Essential Documents Drug/Device Accountability to document that investigational product has been maintained and used according to protocol. Drug/Device shipment and receipt records. Drug/Device Accountability Log.

Essential Documents Data Collection to document all data that is being captured for the study. Blank set of CRFs, data collection sheets, and IRB-approved study questionnaires. If data are being captured electronically a copy of the ecrf completion guidelines could be filed here.

Essential Documents Correspondence to document any agreements or significant discussions regarding trial administration, protocol violations, trial conduct or adverse event reporting. All relevant communications, other than site visits, to document any agreement or significant discussions regarding trial or administration, protocol violations, trial conduct, adverse event reporting, etc. Includes communications to and from the Sponsor and/or the study team. Note: Communications about a specific subject should be filed with source documents for that subject.

Essential Documents Monitoring to document site visits by, and findings of, the monitor. Monitoring Log: Documents any form of study oversight/monitoring. Both the monitor and clinical research coordinator should sign the log. Pre-study Visit Report, Site Initiation Visit Reports, Monitoring Visit Reports, Close-Out visit reports or follow up letters if visit reports are not provided.

Essential Documents Subject Identification Code List to document a confidential list of names of all subjects and their associated unique identifiers. Allows PI to reveal identity of subjects if necessary. This is a document containing a unique identifier assigned by the investigator to each trial subject to protect the subject's identity and used in lieu of the subject's name when the investigator reports adverse events and/or other trial related data. This document allows for decoding in the event of an emergency.

Essential Documents Final Study Report to document completion of trial. Final report by the Investigator to the IRB, and where applicable, to the regulatory authorities to document completion of the trial.

Source Documents

What is source documentation? ICH E6 1.52 source documents Original documents, data and records (e.g., hospital records, clinical and office charts, laboratory notes, memoranda, subjects diaries or evaluation checklists, pharmacy dispensing records, recorded data from automated instruments, copies or transcriptions certified after verification as being accurate copies, microfiches, photographic negatives, microfilm or magnetic media, X-rays, subject files, and records kept at the pharmacy, at the laboratories and at medico-technical departments involved in the clinical trial).

What is source documentation? A source document is first instance a data point is recorded. **Thus it is highly recommended that you create your own data collection tool.

What is source documentation? The most important purpose of source documentation in a clinical trial is to reconstruct the trial as it happened. It should enable an independent observer to reconfirm the data. Documentation should be such that it is able to provide audit trail to permit investigation if and when required.

Source Documentation

What is good source documentation? A Attributable L - Legible C - Contemporaneous O Original A Accurate

Definitions A-Who created record L-Readable C-Timely O-First time written A-Correct, whole truth

Study Execution and ALCOA Informed Consent Study Documentation Source Docs Notes to file and other documentation

Informed Consent Attributable Legible Contemporaneous Original Accurate

Informed Consent Attributable Legible Contemporaneous Original Accurate

Corrections Scribble over mistake Back date note White out mistake Write over mistake

Informed Consent A L C O A

Corrections Single line through Brief Reason Correct data Today s date & initials

What s wrong here? LIAR!! 37 what? 37 point what? That s not inches!! Why is that blank?!

Better! Corrected with a single line trough and initials and date!

What s wrong here? #@& *$!! Did this happen Dec 1 st or Jan 12 th? Oh, now come on December, May? Who knows?!

Better! Ahh, it happened Dec 1st And this is corrected properly. And look, it s even dated the same day!